Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liberum Biotech has developed a proprietary cell-free protein synthesis platform that dramatically accelerates the production of proteins from digital sequence to purified product. Their system allows customers—including academic labs, pharmaceutical companies, and industrial biotech firms—to obtain milligram-scale quantities of custom proteins in as little as two weeks. The company’s technology outperforms traditional cell-based expression systems in speed and cost efficiency. It is already used by over 45 labs worldwide with multiple repeat purchases[5][8]. No direct clinical results are reported since the company provides enabling technology rather than developing its own therapeutic candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Liberum Biotech.